A5019320850- Multiple Sclerosis Research Studies
- Long-Term Effects of COVID-19
- SARS-CoV-2 and COVID-19 Research
- Systemic Lupus Erythematosus Research
- Peripheral Neuropathies and Disorders
- Polyomavirus and related diseases
- Cerebral Palsy and Movement Disorders
- Autoimmune and Inflammatory Disorders Research
- Retinal and Optic Conditions
- Dermatology and Skin Diseases
- Botulinum Toxin and Related Neurological Disorders
- Systemic Sclerosis and Related Diseases
- Fibromyalgia and Chronic Fatigue Syndrome Research
- COVID-19 and Mental Health
- Neurological disorders and treatments
- Family Support in Illness
- Trigeminal Neuralgia and Treatments
- Rheumatoid Arthritis Research and Therapies
- Neurogenesis and neuroplasticity mechanisms
- Stress Responses and Cortisol
- Parkinson's Disease Mechanisms and Treatments
- Urticaria and Related Conditions
- Immunotherapy and Immune Responses
- Infectious Encephalopathies and Encephalitis
- Bacillus and Francisella bacterial research
Isfahan University of Medical Sciences
2020-2025
North Khorasan University of Medical Sciences
2021-2024
Shahrekord University of Medical Sciences
2024
Tehran University of Medical Sciences
2021
Brigham and Women's Hospital
2021
Harvard University
2021
Universal Scientific Education and Research Network
2021
Abstract Background Depression and anxiety are commonly observed in people with multiple sclerosis (pwMS). There is a growing body of literature supporting the hypothesis that personality traits can influence mood disorders. This study aimed to investigate their relationships depression among pwMS. Methods 234 pwMS were involved this cross-sectional study. Personality traits, depression, assessed using NEO Five-Factor Inventory (NEO-FFI) Hospital Anxiety Scale (HADS), respectively. Pearson's...
Fampridine is the only drug approved by US Food and Drug Administration (FDA) for people with multiple sclerosis (MS) to improve their movement has exhibited a clinically significant improvement in gait function subset of MS patients Expanded Disability Status Scale (ESDSS) from 4 7. Nevertheless, this been reported possess some adverse effects (AEs) like seizure because its pharmacological features. The aim study was evaluate incidence rate post-medication side (SEs) fampridine patients....
Cognitive impairment (CI) is prevalent among people with multiple sclerosis (PwMS), significantly affecting their quality of life and functional capacity. While the relationship between CI motor function has been explored in healthy aging other neurological conditions, its association upper lower PwMS remains underexplored. This cross-sectional study analyzed data from 125 (Mage: 37.6 years; median disease duration: 8 years) to examine cognitive outcomes. status was evaluated using Symbol...
Autoimmune demyelinating disorders, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), are caused by persistent inflammation damage to the central nervous system. Cognitive impairment (CI) is a growing challenge in these diseases, underscoring need for thorough exploration of its prevalence risk across various subtypes. This study aimed assess odds CI using Symbol Digit Modalities Test (SDMT) MS subtypes NMOSD. A case-control involving 616 participants,...